A CFO’s perspective on capital allocation, balancing risk and opportunity, and structuring successful China-based clinical programs.
Tony Proctor
Advertisement
Tony Proctor is CFO of Emerald Clinical Trials. He is an expert in financial strategy, corporate finance, M&A, global systems integration, and private equity partnerships. With over 25 years of financial leadership experience, he has held leadership roles at Lexitas, Parexel, and Syneos (formerly INC Research).
Articles by Tony Proctor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform
3
ACT Brief: Real-Time Data Harmonization Infrastructure, Modern Trial Payments, and SCLC Drug Confirmatory Failure
4
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
5